Hudson Executive Capital LP - ACORDA THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Hudson Executive Capital LP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2018$31,140,000
+10.3%
1,316,7000.0%9.19%
-32.3%
Q4 2017$28,243,000
-33.2%
1,316,700
-26.3%
13.56%
+27.6%
Q3 2017$42,262,000
+38.7%
1,787,000
+15.6%
10.63%
+51.8%
Q2 2017$30,460,0001,546,1807.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 428,000$8,046,0001.90%
SCOPIA CAPITAL MANAGEMENT LP 4,532,067$85,203,0001.61%
DLD Asset Management, LP 247,300$4,656,0001.52%
Broadfin Capital, LLC 644,153$12,110,0001.34%
Perceptive Advisors 720,000$13,536,0000.96%
DLD Asset Management, LP 135,493$2,547,0000.83%
Malaga Cove Capital, LLC 51,013$971,0000.64%
Baker Brothers Advisors 3,301,791$62,074,0000.61%
Worth Venture Partners, LLC 29,300$551,0000.59%
Spark Investment Management LLC 327,900$6,164,0000.51%
View complete list of ACORDA THERAPEUTICS INC shareholders